Capstone Therapeutics Corp.
|
-36.39 USD
|
99.643%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
97.579%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
102.185%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-870.149%
|
Qrons Inc.
|
-0.06 USD
|
-122.985%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
79.032%
|
CSL Limited
|
2.73 USD
|
104.762%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
101.256%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
94.273%
|
Regen BioPharma, Inc.
|
0.26 USD
|
150.0%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-126.087%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-1200.0%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-304.984%
|
Burzynski Research Institute, Inc.
|
-0.01 USD
|
-1174.51%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-8566.667%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
50.0%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
99.744%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-152.427%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
95.29%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-48.741%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-448.523%
|
Mesoblast Limited
|
-0.09 USD
|
-45.903%
|
Marizyme, Inc.
|
-1.44 USD
|
90.972%
|
Genus plc
|
0.12 USD
|
208.333%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
94.421%
|
Pharming Group N.V.
|
-0.02 USD
|
-707.453%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-18471.429%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
69.048%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-34.715%
|
ContraFect Corporation
|
-124.97 USD
|
99.896%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-209.524%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-983.333%
|
IMV Inc.
|
-4.37 USD
|
97.025%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-267.232%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-129900.0%
|
ONE Bio Corp.
|
1.43 USD
|
109.091%
|
Accustem Sciences Inc.
|
-0.34 USD
|
61.765%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
77.586%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-8.333%
|
Q BioMed Inc.
|
-0.08 USD
|
-66.453%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-84.922%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
60.606%
|
Biomind Labs Inc.
|
-0.02 USD
|
-702.469%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.983%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-1656.757%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-553.266%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-5316.667%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-16150.0%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-1377.273%
|
GB Sciences, Inc.
|
-0.00 USD
|
-3070.732%
|
Alpha Cognition Inc.
|
-0.15 USD
|
13.333%
|
HST Global, Inc.
|
-0.03 USD
|
-365.95%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-159.481%
|
Halberd Corporation
|
-0.00 USD
|
-129900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-18471.429%
|
Agentix Corp.
|
-0.04 USD
|
-271.429%
|
Resverlogix Corp.
|
-0.01 USD
|
-815.493%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-72.414%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
97.481%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
10100.0%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
617.928%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-264.146%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-550.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-141.187%
|
Zenith Capital Corp.
|
-0.07 USD
|
-85.98%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-186.344%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-1963.492%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
96.552%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-25900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-42.388%
|
Kadimastem Ltd
|
-0.78 USD
|
83.333%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
97.234%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-992.437%
|
LadRx Corporation
|
0.68 USD
|
119.118%
|
Cell Source, Inc.
|
-0.17 USD
|
23.529%
|
Regen BioPharma, Inc.
|
0.29 USD
|
144.828%
|
NovAccess Global Inc.
|
-0.23 USD
|
43.478%
|
Affymax, Inc.
|
-0.39 USD
|
66.667%
|
Itoco Inc.
|
-0.01 USD
|
-1610.526%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-1200.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-5100.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-2221.429%
|
CytoDyn Inc.
|
-0.05 USD
|
-145.747%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-25900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-485.586%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.915%
|
SYBLEU INC
|
-0.02 USD
|
-642.857%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-815.493%
|
International Stem Cell Corporation
|
-0.02 USD
|
-692.683%
|
Bioxytran, Inc.
|
-0.03 USD
|
-307.524%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-129900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
98.373%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
88.983%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-282.353%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-1963.492%
|
Neutra Corp.
|
-0.00 USD
|
-129900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.862%
|
PureTech Health plc
|
-2.38 USD
|
94.538%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
84.337%
|
IXICO plc
|
-0.02 USD
|
-432.787%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-128.873%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
90.37%
|
CSL Limited
|
5.47 USD
|
102.377%
|
Cellectis S.A.
|
-1.77 USD
|
92.655%
|